IEX •
Healthcare •
Biotechnology •
Quote as of 07/01/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization126.18 mln
Float38.87 mln
Earnings Date08/11/2026
EPS
2.05
Solid
P / E
1.66
Deeply undervalued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
26.77
Highly suspicious
Relative Strength
93
/ 100
Top performer
Debt / Equity
-0.19
Negative equity
Business Description
Agenus Inc. is a US-based biotech company founded in 1994 and headquartered in Lexington, Massachusetts, focused on developing treatments that use the body's immune system to fight cancer and infectious diseases. The company has a broad pipeline of experimental drugs at various stages of clinical testing, along with proprietary technology platforms used to discover and create antibody-based therapies. Agenus works alongside several major pharmaceutical partners, including Merck, Gilead Sciences, Bristol-Myers Squibb, and Incyte Corporation, to advance these treatments toward patients.
